Saw palmetto dosage for benign prostatic hyperplasia
Pro Research Analysisby 
Searched over 200M research papers
Saw Palmetto Dosage for Benign Prostatic Hyperplasia: Clinical Evidence
Standard Saw Palmetto Dosage for BPH
Most clinical studies and trials investigating saw palmetto for benign prostatic hyperplasia (BPH) use a daily dosage of 320 mg, typically administered as a standardized extract in capsule form, either as a single dose or split into two doses of 160 mg each per day 234567910. This dosage has been the most common in both research and clinical practice.
Efficacy of 320 mg Saw Palmetto Daily
Several studies have shown that 320 mg per day of saw palmetto extract can lead to improvements in lower urinary tract symptoms (LUTS) associated with BPH, as measured by reductions in the International Prostate Symptom Score (IPSS) and improvements in quality of life 2346710. Some studies also report increased urine flow rate and decreased post-void residual urine volume with this dosage 47.
Comparison with Other Treatments
In head-to-head studies, 320 mg of saw palmetto daily was found to be as effective as other phytotherapies like D-004 (a lipid extract from Roystonea regia) in reducing LUTS in men with moderate BPH . Combination therapy of saw palmetto (320 mg) with tamsulosin (0.4 mg) showed even greater improvements in symptom scores, urine flow, and prostate volume compared to either treatment alone 710.
Safety and Side Effects
Saw palmetto at 320 mg per day is generally well tolerated, with mild side effects reported in a small number of patients, such as mild stomachache . Serious adverse events are rare 2347910.
Mixed Evidence on Objective Measures
While some studies report significant improvements in symptoms and quality of life, others found no significant difference between saw palmetto (320 mg/day) and placebo in terms of symptom scores, urinary flow rate, prostate size, or PSA levels over a 12-month period 59. This suggests that while some patients may benefit, the overall effect may be modest or variable.
Higher Dosages and Enriched Extracts
Animal studies have explored higher dosages (200–400 mg/kg in rats) and enriched extracts (such as β-sitosterol-enriched saw palmetto oil), showing greater efficacy in reducing prostate enlargement and regulating inflammatory markers compared to conventional extracts . However, these higher dosages have not been directly translated to human studies, and the standard human dose remains 320 mg per day.
Conclusion
The most commonly studied and recommended dosage of saw palmetto for benign prostatic hyperplasia is 320 mg per day, usually as a standardized extract. This dosage has shown potential benefits in improving urinary symptoms and quality of life for some men with BPH, with a good safety profile. However, clinical results are mixed, and not all studies show significant improvements over placebo. Combination therapy with other medications may enhance benefits. Higher or enriched extracts show promise in animal studies, but more research is needed for human recommendations.
Sources and full results
Most relevant research papers on this topic